The Board proposes the development of a rule amendment to address prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
RULE NO.:RULE TITLE:
64B8-9.0141Standards for Telemedicine Practice
PURPOSE AND EFFECT: The Board proposes the development of a rule amendment to address prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
SUBJECT AREA TO BE ADDRESSED: The prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
RULEMAKING AUTHORITY: 458.331(1)(v) FS.
LAW IMPLEMENTED: 458.331(1)(v) FS.
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Adrienne Rodgers, Interim Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253
THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.
Document Information
- Subject:
- The prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
- Purpose:
- The Board proposes the development of a rule amendment to address prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
- Rulemaking Authority:
- 458.331(1)(v), FS.
- Law:
- 458.331(1)(v), FS.
- Contact:
- Adrienne Rodgers, Interim Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253.
- Related Rules: (1)
- 64B8-9.0141. Standards for Telemedicine Practice